Adaptive Biotechnologies ADPT Stock
Adaptive Biotechnologies Price Chart
Adaptive Biotechnologies ADPT Financial and Trading Overview
| Adaptive Biotechnologies stock price | 17.36 USD |
| Previous Close | 11.69 USD |
| Open | 11.4 USD |
| Bid | 12.52 USD x 1500 |
| Ask | 12.66 USD x 1600 |
| Day's Range | 11.4 - 12.92 USD |
| 52 Week Range | 3.98 - 12.92 USD |
| Volume | 5.01M USD |
| Avg. Volume | 1.87M USD |
| Market Cap | 1.91B USD |
| Beta (5Y Monthly) | 1.925 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.81 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.71 USD |
ADPT Valuation Measures
| Enterprise Value | 1.93B USD |
| Trailing P/E | N/A |
| Forward P/E | -13.3404255 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.304908 |
| Price/Book (mrq) | 10.61812 |
| Enterprise Value/Revenue | 9.402 |
| Enterprise Value/EBITDA | -18.762 |
Trading Information
Adaptive Biotechnologies Stock Price History
| Beta (5Y Monthly) | 1.925 |
| 52-Week Change | 180.53% |
| S&P500 52-Week Change | 18.63% |
| 52 Week High | 12.92 USD |
| 52 Week Low | 3.98 USD |
| 50-Day Moving Average | 10.78 USD |
| 200-Day Moving Average | 8.05 USD |
ADPT Share Statistics
| Avg. Volume (3 month) | 1.87M USD |
| Avg. Daily Volume (10-Days) | 2.34M USD |
| Shares Outstanding | 152.27M |
| Float | 117.37M |
| Short Ratio | 3.89 |
| % Held by Insiders | 2.34% |
| % Held by Institutions | 95.00% |
| Shares Short | 9.69M |
| Short % of Float | 8.16% |
| Short % of Shares Outstanding | 6.37% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -59.074% |
| Operating Margin (ttm) | -42.52% |
| Gross Margin | 61.25% |
| EBITDA Margin | -50.11% |
Management Effectiveness
| Return on Assets (ttm) | -13.99% |
| Return on Equity (ttm) | -57.59% |
Income Statement
| Revenue (ttm) | 205.22M USD |
| Revenue Per Share (ttm) | 1.38 USD |
| Quarterly Revenue Growth (yoy) | 36.29% |
| Gross Profit (ttm) | 125.71M USD |
| EBITDA | -102837000 USD |
| Net Income Avi to Common (ttm) | -121229000 USD |
| Diluted EPS (ttm) | -0.81 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 197.87M USD |
| Total Cash Per Share (mrq) | 1.3 USD |
| Total Debt (mrq) | 217.94M USD |
| Total Debt/Equity (mrq) | 121.39 USD |
| Current Ratio (mrq) | 2.842 |
| Book Value Per Share (mrq) | 1.181 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -80470000 USD |
| Levered Free Cash Flow (ttm) | -18756124 USD |
Profile of Adaptive Biotechnologies
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 1165 Eastlake Avenue East |
| ZIP | 98109 |
| Phone | 206 659 0067 |
| Website | https://www.adaptivebiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 619 |
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. It has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Q&A For Adaptive Biotechnologies Stock
What is a current ADPT stock price?
Adaptive Biotechnologies ADPT stock price today per share is 17.36 USD.
How to purchase Adaptive Biotechnologies stock?
You can buy ADPT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adaptive Biotechnologies?
The stock symbol or ticker of Adaptive Biotechnologies is ADPT.
Which industry does the Adaptive Biotechnologies company belong to?
The Adaptive Biotechnologies industry is Biotechnology.
How many shares does Adaptive Biotechnologies have in circulation?
The max supply of Adaptive Biotechnologies shares is 152.27M.
What is Adaptive Biotechnologies Price to Earnings Ratio (PE Ratio)?
Adaptive Biotechnologies PE Ratio is now.
What was Adaptive Biotechnologies earnings per share over the trailing 12 months (TTM)?
Adaptive Biotechnologies EPS is -0.81 USD over the trailing 12 months.
Which sector does the Adaptive Biotechnologies company belong to?
The Adaptive Biotechnologies sector is Healthcare.
Adaptive Biotechnologies ADPT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech US 700 Small Cap Index NQUS700SC | 2566.34 USD — |
+0.47
|
— — | 2546.3 USD — | 2571.79 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 3514.71 USD — |
+0.87
|
— — | 3485.13 USD — | 3527.41 USD — | — - | — — |
| US Tech Biotechnology NBI | 5366.46 USD — |
+1.2
|
— — | 5276.16 USD — | 5372.71 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 11620.1 USD — |
+0.59
|
— — | 11575.56 USD — | 11733.88 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}